Interplay between Epigenetics & Cancer Metabolism

E-ISSN： 1873-4286|20|11|1706-1714

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.11, 2014-04, pp. : 1706-1714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topic: Cross-Talking Metabolism and Epigenetics in Anti-Cancer Drug Design)

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 529-531

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetics of cancer progression

By Vucic Emily A Brown Carolyn J Lam Wan L

Pharmacogenomics, Vol. 9, Iss. 2, 2008-02 ,pp. : 215-234

Future Medicine

Access to resources Recommend Favorite

Editorial: Cancer Epigenetics

Current Cancer Drug Targets, Vol. 18, Iss. 1, 2017-12 ,pp. : 3-4

Bentham Science Publishers

Access to resources Recommend Favorite

The Interplay between Indoleamine 2,3-Dioxygenase 1 (IDO1) and Cyclooxygenase (COX)-2 In Chronic Inflammation and Cancer

Current Medicinal Chemistry, Vol. 18, Iss. 15, 2011-05 ,pp. : 2263-2271

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetics: an emerging technology in the diagnosis and treatment of cancer

By Stebbing Justin Bower Mark Syed Nelofer Smith Paul Yu Veronica Crook Tim

Pharmacogenomics, Vol. 7, Iss. 5, 2006-07 ,pp. : 747-757

Future Medicine

Access to resources Recommend Favorite